Research is being conducted to understand the potential mechanism of hesperetin on chronic obstructive pulmonary disease (COPD) using integrated network pharmacology, molecular docking, and animal experiments. Similar studies have been done on various other substances and their effects on different diseases, including inflammatory bowel disease, periodontitis, and cervical cancer. The use of integrated network pharmacology, molecular docking, and experimental validation appears to be a common approach in investigating the potential mechanisms of various compounds on different health conditions.